Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin Hohl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $51.68M of ELVN open-market activity in the last 12 months
- Mika K. Derynck - $9.56M of ELVN open-market activity in the last 12 months
- Helen Louise Collins - $5.14M of ELVN open-market activity in the last 12 months
- Joseph P. Lyssikatos - $4.96M of ELVN open-market activity in the last 12 months
- Anish Patel - $1.74M of ELVN open-market activity in the last 12 months
- Lori Anne Kunkel - $850K of ELVN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Benjamin Hohl?
Benjamin Hohl is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Enliven Therapeutics, Inc. (ELVN). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Benjamin Hohl submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Benjamin Hohl been buying or selling stock?
Recorded transactions: 0 open-market purchases and 30 open-market sales ($2.43M) across all tracked filings.
Where can I see all of Benjamin Hohl's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Benjamin Hohl and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
